2026-01-26
Once considered an irreversible "forbidden zone," the spinal cord is now gradually overcoming this cognitive barrier with the advent of NEAT technology. Harnessing the power of science and technology, more patients who have lost mobility due to neural injuries may one day see the dawn of regaining their ability to stand and live independently.
2026-01-26
This research advances the intersection of bioengineering and neuroscience. The constructed "human cerebral vascular chip" represents the first comprehensive simulation of the human cerebral vascular system from structure to function. It provides an unprecedented in vitro platform for exploring cerebral blood flow regulation, BBB mechanisms, and brain diseases closely related to vasculature, such as neuroinflammation, Alzheimer's disease, and stroke.
2026-01-19
Published in Nature, this research marks a shift in tumor immunotherapy from “target blockade” to “cellular fate reprogramming.” With ongoing optimization and clinical exploration of the iVAC platform, it holds promise as a core tool for the next generation of immunotherapies, offering new hope to millions of cancer patients.
2025-12-19
Scientists Crack the "Xenogeneic Barrier", Offering a New Path for Growing Human Organs in Animals
For a long time, human cells have often been excluded and struggled to survive in animal embryos due to the "xenogeneic barrier." The mainstream strategy in the past involved genetically engineering human cells to enhance their anti-apoptotic capabilities, but this approach carries potential safety risks such as carcinogenesis. How can this barrier be overcome more safely? A collaborative team led by the University of Texas Southwestern Medical Center and BGI Research used mice as a model to tackle this issue and achieved a critical breakthrough.
2025-12-12
No Need for Open-Chest Surgery: Stem Cell Patch Enables Minimally Invasive Heart Repair
Recently, a joint research team from the Mayo Clinic and the University of Nebraska Medical Center published a breakthrough study in the Journal of Biomedical Materials Research—they successfully developed a minimally implantable stem cell patch that can repair damaged hearts without open-chest surgery, providing a safer treatment option for heart failure patients. This achievement signifies the deep integration of regenerative medicine and minimally invasive interventional technology, which is expected to reshape the clinical approach to heart repair.
2025-12-12
Tsinghua University Team Makes New Progress in Cross-Scale Biological Sample Cryopreservation
Cryopreservation technology, as a key support for cell therapy, regenerative medicine, organ transplantation, and biological resource preservation, has long been constrained by ice crystal damage—from single cells to complex organs, the formation, propagation, and recrystallization of ice during rewarming progressively amplify structural and functional damage. Recently, Assistant Professor Geng Hongya’s team at Tsinghua Shenzhen International Graduate School has achieved a breakthrough in cross-scale biological sample cryopreservation. The related findings were published in the top international journal Advanced Materials, offering innovative solutions to two core challenges: low-temperature ice inhibition and efficient rewarming.
2025-11-28
This research represents a solid step toward this long-term goal at the scientific and technological foundation level. With the continuous iteration of related technologies, organ banks, once confined to science fiction, may become a reality, bringing hope to millions of patients worldwide awaiting organ transplants.
2025-11-28
A University of Virginia research team has pioneered a novel 3D-printable material compatible with the human immune system, as reported in the latest issue of Advanced Materials.
2025-11-21
Industry experts believe that this study marks a critical breakthrough for China in the field of tumor immunotherapy. It provides important insights for CAR-T therapy to tackle other solid tumors, such as lung and liver cancer, and will elevate China's level of tumor immunotherapy to new heights.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
